Jan 21, 2026
cancer treatments
is marked by a rapid shift from one‑size‑fits‑all chemotherapy to — including blood‑based minimal residual disease (MRD) testing to tailor adjuvant therapy, expanded cell and radioligand therapies, ne...
Your fact-checks will appear here
Cancer incidence has been roughly stable or only modestly changing since 2020, but several specific cancers show clear upward trends